Cited by 66Reproductive System and PregnancyMenstrual Health and DisordersAngiogenesis and VEGF in Cancer

Progesterone Withdrawal Up-Regulates Vascular Endothelial Growth Factor Receptor Type 2 in the Superficial Zone Stroma of the Human and Macaque Endometrium: Potential Relevance to Menstruation

Nayak, N. R.·2000·Journal of Clinical Endocrinology & Metabolism

Abstract

Several reports indicate that vascular endothelial growth factor (VEGF) expression is increased in endometrial glands and stroma during the menstrual phase in the human endometrium. Here we report that VEGF receptor type 2 (KDR), normally expressed only in the vascular endothelium, was dramatically up-regulated in the stromal cells of the superficial endometrial zones during the premenstrual phase in both human and macaque endometrium. This increase was detectable by Northern analysis, in situ hybridization, and immunocytochemistry and was cell specific, zone specific, cycle phase specific, and VEGF receptor type specific. That is, it only occurred during the premenstrual/menstrual phase, did not occur in glandular epithelium, endothelium, or stromal cells of the deepest endometrial zones, and was not observed for VEGF receptor type 1. The upregulation of stromal KDR was induced by progesterone (P) withdrawal in both women and macaques, and adding back P 24 h after P withdrawal in macaques blocked stromal, but not vascular, endothelial KDR expression. Promatrix metalloproteinase-1 (MMP-1) was coordinately up-regulated in the same stromal cell population by P withdrawal. Because of reports that VEGF can enhance MMP expression, we hypothesize that VEGF-KDR interactions may influence MMP expression in the superficial zones of the primate endometrium during the premenstrual phase, and that these interactions play a role in the induction of menstruation.

Integrity signals

Registry

Crossref · 10.1210/jc.85.9.3442

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • VEGF and its receptor VEGFR-2/KDR are markedly up-regulated in superficial endometrial stromal cells in human and non-human primate models.

    “VEGF and its receptor VEGFR-2 kinase insert domain receptor (KDR) are markedly up-regulated in superficial endometrial stromal cells in human and non-human primate models”

Cites

The publisher hasn’t deposited this paper’s reference list.

Cited by

Sorted by citations

Authors
Nayak, N. R.
Affiliations
Oregon National Primate Research Center (US)
Venue
Journal of Clinical Endocrinology & Metabolism
Published
2000-09-01
Volume
85
Issue
9
Pages
3442-3452
ISSN
0021-972X (ISSN-L)
OpenAlex
W2070456737
Cited by
66
References
0
Citations by year
2024: 2 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
  • U.S. Public Health Service (U5418185)
  • National Center for Research Resources (RR-00163.)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19182, R01HD019182)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
progesterone withdrawal, KDR, endometrial stroma, menstruation, premenstrual phase, MMP-1, vascular endothelial growth factor, human endometrium, menstrual cycle
MeSH terms
Adult, Animals, Antibody Specificity, Endometrium, Female, Humans, Immunohistochemistry, Macaca mulatta, Menstruation, Progesterone, Proto-Oncogene Proteins, RNA, Messenger, Steroids, Substance Withdrawal Syndrome, Blotting, Northern, Cell Hypoxia, Up-Regulation, Stromal Cells, In Situ Hybridization, Receptors, Growth Factor, Reverse Transcriptase Polymerase Chain Reaction, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review